Emergent Metals Corp. - EMR.V

EMR.V Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
EMR.V	-4.8	-13.0	17.6	81.8	100	-23.1	-75	-83.3	-95	-100.0
S&P 500	0.4	-1.6	0.5	5.1	11.1	29.6	25.5	88.9	187.7	33272.7

Compare EMR.V with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	EMR.V
name	Emergent Metals Corp.
price	0.10
changes percentage	-4.76
change	-0.01
day low	0.10
day high	0.11
year high	0.14
year low	0.03
market cap	3210870
price avg 50	0.08
price avg 200	0.06
exchange	TSXV
volume	160950
avg volume	139145
open	0.10
previous close	0.10
eps	-0.06
pe	-1.67
earnings announcement	2025-06-27T10:00:00.000+0000
shares outstanding	32108700
timestamp	2024-11-18 19:00:24

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 10.0%

Overall Quarterly Financial Health: 35.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	0	0	NaN
gross profit	0	-26751	100.00
gross profit ratio	0	0	NaN
research and development expenses	0	0	NaN
operating expenses	825	2293395	-99.96
interest income	1.25	0	NaN
interest expense	0	3845	-100.00
ebitda	-1586.43	-2218266	99.93
ebitdaratio	0	0	NaN
operating income	-1595.91	-2245017	99.93
operating income ratio	0	0	NaN
net income	-826.25	-1570883	99.95
net income ratio	0	0	NaN
eps	0	-0.09	100.00

Overall Score of Annual Income Statement

None

Detailed Analysis

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q1	2023Q4	Q/Q change %
0000000000
revenue	0	0	NaN
gross profit	-1885	-5831	67.67
gross profit ratio	0	0	NaN
research and development expenses	0	0	NaN
operating expenses	28676	983.88	2,814.58
interest income	167	0.53	31,350.09
interest expense	966	0	NaN
ebitda	-179654	-978050	81.63
ebitdaratio	0	0	NaN
operating income	0	-656.33	100.00
operating income ratio	0	0	NaN
net income	27710	-983.35	2,917.92
net income ratio	0	0	NaN
eps	0.0	0	NaN

Overall Score of Quarterly Income Statement

None

Detailed Analysis

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	2918096	3956338	-26.24
total liabilities	1931567	2612778	-26.07
total equity	986529	1343560	-26.57
cash and cash equivalents	224525	688124	-67.37
short term investments	0	222153	-100.00
long term investments	0	0	NaN
total current assets	357298	1239015	-71.16
total non current assets	2560798	2717323	-5.76
total current liabilities	1931567	2612778	-26.07
total non current liabilities	0	0	NaN
common stock	49111305	48838993	0.56
retained earnings	-57202331	-56376080	-1.47
total debt	26603	16792	58.43

Overall Score of Annual Balance Sheet

0.3 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 3 million in 2023 from 4 million in 2022 representing a change of -26.24%. Suggesting a decrease in asset holdings.

  Total Equity: Total Equity decreased to 1 million in 2023 from 1 million in 2022 representing a change of -26.57%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 0 million in 2023 from 1 million in 2022 representing a change of -67.37%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 0 million in 2023 from 0 million in 2022 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 0 million in 2023 from 1 million in 2022 representing a change of -71.16%. This indicates a worsen liquidity position.

  Retained Earnings: Retained Earnings decreased to -57 million in 2023 from -56 million in 2022 representing a change of -1.47%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 0 million in 2023 from 0 million in 2022 representing a change of 58.43%. This indicates an increase in overall debt burden.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 2 million in 2023 from 3 million in 2022 representing a change of -26.07%. This indicates a decrease in overall liabilities.

  Total Current Liabilities: Total Current Liabilities decreased to 2 million in 2023 from 3 million in 2022 representing a change of -26.07%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 49 in 2023 from 49 in 2022 representing a change of 0.56%. This indicates an increase in ownership interest.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q1	2023Q4	Q/Q change %
0000000000
total assets	2704540	2918096	-7.32
total liabilities	1682910	1931567	-12.87
total equity	1021630	986529	3.56
cash and cash equivalents	187126	224525	-16.66
short term investments	0	0	NaN
long term investments	0	0	NaN
total current assets	313685	357298	-12.21
total non current assets	2390855	2560798	-6.64
total current liabilities	1682910	1931567	-12.87
total non current liabilities	0	0	NaN
common stock	49111305	49111305	0.00
retained earnings	-57174621	-57202331	0.05
total debt	26996	26603	1.48

Overall Score of Quarterly Balance Sheet

0.5 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 3 million in 2024Q1 from 3 million in 2023Q4 representing a change of -7.32%. Suggesting a decrease in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 0 million in 2024Q1 from 0 million in 2023Q4 representing a change of -16.66%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 0 million in 2024Q1 from 0 million in 2023Q4 representing a change of -12.21%. This indicates a worsen liquidity position.

  Total Debt: Total Debt increased to 0 million in 2024Q1 from 0 million in 2023Q4 representing a change of 1.48%. This indicates an increase in overall debt burden.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 2 million in 2024Q1 from 2 million in 2023Q4 representing a change of -12.87%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 1 million in 2024Q1 from 1 million in 2023Q4 representing a change of 3.56%. This indicates an increase in shareholders' equity.

  Total Current Liabilities: Total Current Liabilities decreased to 2 million in 2024Q1 from 2 million in 2023Q4 representing a change of -12.87%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to -57 million in 2024Q1 from -57 million in 2023Q4 representing a change of 0.05%. This indicates an accumulated profits.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-463599	330812	-240.14
operating cash flow	-1098341	-2125806	48.33
free cash flow	-1151315	-2175361	47.07
capital expenditure	-52974	-49555	-6.90
depreciation and amortization	23659	26751	-11.56
deferred income tax	0	0	NaN
stock based compensation	184.95	0	NaN
accounts payables	0	191400	-100.00
inventory	0	46.13	-100.00
acquisitions net	0	0	NaN
investments in property plant and equipment	-52974	-49555	-6.90
net cash used for investing activites	194779	732703	-73.42
debt repayment	8210	-18245	145.00
common stock issued	390777	1770022	-77.92
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	439963	1751777	-74.88
cash at end of period	224525	688124	-67.37
accounts receivables	98128	-46.13	212,802.13
cash at beginning of period	688124	357312	92.58

Overall Score of Annual Cashflow Statement

None

Detailed Analysis

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q1	2023Q4	Q/Q change %
0000000000
operating cash flow	-204941	-39749	-415.59
free cash flow	-337849	-39749	-749.96
capital expenditure	-132908	0	NaN
depreciation and amortization	2831	5831	-51.45
deferred income tax	0	0	NaN
stock based compensation	7391	132961	-94.44
accounts receivables	197	1157	-82.97
accounts payables	-71646	758553	-109.45
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	-132908	0	NaN
net cash used for investing activites	167092	-1399	12,043.67
debt repayment	0	20620	-100.00
common stock issued	0	261093	-100.00
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	0	250049	-100.00
net change in cash	-37399	209174	-117.88
cash at end of period	187126	224525	-16.66
cash at beginning of period	224525	15351	1,362.61

Overall Score of Quarterly Cashflow Statement

0.57 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to 0 million in 2024Q1 from 0 million in 2023Q4 representing a change of -117.88%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 0 million in 2024Q1 from 0 million in 2023Q4 representing a change of -415.59%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 0 million in 2024Q1 from 0 million in 2023Q4 representing a change of -749.96%. This indicates a decrease in cash generated after accounting for capital expenditures.

• 📈 Positive Indicators

  Capital Expenditure: Capital Expenditure decreased to 0 million in 2024Q1 from 0 million in 2023Q4 representing a change of nan%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2024Q1 from 0 million in 2023Q4 representing a change of -94.44%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2024Q1 from 1 million in 2023Q4 representing a change of -109.45%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to 0 million in 2024Q1 from 0 million in 2023Q4 representing a change of -82.97%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	0	0	NaN
net income per share	-0.0	-0.09	99.97
operating cash flow per share	-0.04	-0.12	66.67
free cash flow per share	-0.04	-0.12	65.86
cash per share	0.01	0.05	-84.09
book value per share	0.04	0.07	-52.64
tangible book value per share	0.04	0.07	-52.64
shareholders equity per share	0.04	0.07	-52.64
interest debt per share	0.0	0.0	346.27
market cap	1884654.37	3304080.29	-42.96
enterprise value	1686732.37	2632748.29	-35.93
pe ratio	-2280.97	-2.1	-108,345.86
price to sales ratio	0	0	NaN
pocfratio	-1.72	-1.55	-10.40
pfcf ratio	-1.64	-1.52	-7.78
pb ratio	1.91	2.46	-22.32
ptb ratio	1.91	2.46	-22.32
ev to sales	0	0	NaN
enterprise value over ebitda	-1063.22	-1.19	-89,483.53
ev to operating cash flow	-1.54	-1.24	-24.00
ev to free cash flow	-1.47	-1.21	-21.05
earnings yield	-0.0	-0.48	99.91
free cash flow yield	-0.61	-0.66	7.21
debt to equity	0.03	0	NaN
debt to assets	0.01	0	NaN
net debt to ebitda	124.76	0.3	41,123.80
current ratio	0.18	0.47	-60.99
interest coverage	0	-583.88	100.00
income quality	1.33	1.35	-1.77
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0	0	NaN
capex to operating cash flow	-0.05	-0.02	-106.90
capex to revenue	0	0	NaN
capex to depreciation	2.24	1.85	20.87
stock based compensation to revenue	0	0	NaN
graham number	0.0	0.38	-98.73
roic	0.32	-1.76	118.10
return on tangible assets	-0.0	-0.4	99.93
graham net net	-0.06	-0.09	32.50
working capital	-1574269	-1373763	-14.60
tangible asset value	986529	1343560	-26.57
net current asset value	-1574269	-1373763	-14.60
invested capital	986529	1222720	-19.32
average receivables	0	32957.5	-100.00
average payables	1183399	921881	28.37
average inventory	71263.5	90141.5	-20.94
days sales outstanding	0	0	NaN
days payables outstanding	0	14054.79	-100.00
days of inventory on hand	0	1944.69	-100.00
receivables turnover	0	0	NaN
payables turnover	0	0.03	-100.00
inventory turnover	0	0.19	-100.00
roe	-0.0	-1.17	99.93
capex per share	0.0	0.0	-31.05

• Negative

  ROE: Return on Equity (ROE) increased to -0.00 on 2023-12-31 from -1.17 on 2022-12-31, representing a change of 99.93%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -2280.97 on 2023-12-31 from -2.10 on 2022-12-31, representing a change of -108345.86%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio decreased to 0.18 on 2023-12-31 from 0.47 on 2022-12-31, representing a change of -60.99%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.

• Quarterly Financial Ratios

	2024-03-31 Q1	2023-12-31 Q4	Q/Q change %
EMR.V
calendar year	2024	2023	NaN
revenue per share	0	0	NaN
net income per share	0.0	-0.0	2,526.82
operating cash flow per share	-0.01	-0.0	-344.03
free cash flow per share	-0.01	-0.0	-631.99
cash per share	0.01	0.01	-28.22
book value per share	0.03	0.04	-10.81
tangible book value per share	0.03	0.04	-10.81
shareholders equity per share	0.03	0.04	-10.81
interest debt per share	0.0	0.0	-9.48
market cap	1655137.72	1876263.47	-11.79
enterprise value	1495007.72	1678341.47	-10.92
pe ratio	14.93	-477.01	103.13
price to sales ratio	0	0	NaN
pocfratio	-8.08	-47.2	82.89
pfcf ratio	-4.9	-47.2	89.62
pb ratio	1.62	1.9	-14.82
ptb ratio	1.62	1.9	-14.82
ev to sales	0	0	NaN
enterprise value over ebitda	-8.32	-1.72	-384.94
ev to operating cash flow	-7.29	-42.22	82.72
ev to free cash flow	-4.43	-42.22	89.52
earnings yield	0.02	-0.0	3,294.39
free cash flow yield	-0.2	-0.02	-863.51
debt to equity	0.03	0.03	-2.01
debt to assets	0.01	0.01	9.49
net debt to ebitda	0.89	0.2	340.46
current ratio	0.19	0.18	0.77
interest coverage	0	0	NaN
income quality	-7.4	0.04	-18,396.76
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0	0	NaN
capex to operating cash flow	-0.65	0	NaN
capex to revenue	0	0	NaN
capex to depreciation	46.95	0	NaN
stock based compensation to revenue	0	0	NaN
graham number	0.02	0.01	365.23
roic	0	0.03	-100.00
return on tangible assets	0.01	-0.0	3,140.43
graham net net	-0.04	-0.06	26.94
working capital	-1369225	-1574269	13.02
tangible asset value	1021630	986529	3.56
net current asset value	-1369225	-1574269	13.02
invested capital	1021630	986529	3.56
average receivables	44500	17928	148.22
average payables	1294094	957440.5	35.16
average inventory	22509.5	37464	-39.92
days sales outstanding	0	0	NaN
days payables outstanding	59751.93	20631.89	189.61
days of inventory on hand	0	694.86	-100.00
receivables turnover	0	0	NaN
payables turnover	0.0	0.0	-65.47
inventory turnover	0	0.13	-100.00
roe	0.03	-0.0	2,821.10
capex per share	0.0	0	NaN

• Negative

  ROE: Return on Equity (ROE) increased to 0.03 on 2024-03-31 Q1 from -0.00 on 2023-12-31 Q4, representing a change of 2821.10%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio increased to 0.19 on 2024-03-31 Q1 from 0.18 on 2023-12-31 Q4, representing a change of 0.77%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. However, it's below 1, indicating potential liquidity issues.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 14.93 on 2024-03-31 Q1 from -477.01 on 2023-12-31 Q4, representing a change of 103.13%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.03 on 2024-03-31 Q1 from 0.03 on 2023-12-31 Q4, representing a change of -2.01%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 0.01 which is lower than current price 0.1, indicates the company may be overvalued.